Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16 studies found for:    LAM | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
LAM | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: albuterol inhaler;   Procedure: PFT;   Drug: albuterol nebulizer
2 Recruiting Study of the Disease Process of Lymphangioleiomyomatosis
Conditions: Lung Disease;   Pneumothorax;   Tuberous Sclerosis
Intervention:
3 Recruiting Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Intervention: Drug: sirolimus and hydroxychloroquine
4 Unknown  Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Interventions: Drug: Letrozole;   Drug: Placebo
5 Recruiting Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Conditions: Pulmonary Disease;   Oropharyngeal Disease;   Lymphangioleiomyomatosis;   Pulmonary Fibrosis;   Asthma;   Sarcoidosis
Intervention:
6 Recruiting Optimizing Clinical Outcomes in HIV-Infected Adults & Children
Conditions: Tuberculosis Diagnosis;   HIV
Intervention: Other: Xpert MTB/RIF Tuberculosis diagnostic tool
7 Recruiting VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Device: SECONDARY dressing gauze and tape;   Procedure: debridement, irrigation;   Device: Dermagraft™;   Device: Oasis™
8 Recruiting Clinical and Genetic Characterization of Individuals With Achromatopsia
Condition: Achromatopsia
Intervention:
9 Recruiting Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Condition: Congenital Disorders of Glycosylation
Intervention:
10 Not yet recruiting Evaluation of an Integrated Microfinance and Depression Care Program for Women
Conditions: Depression;   Anxiety
Interventions: Behavioral: LIFE-DM;   Drug: Guideline Antidepressant Care
11 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
Intervention:
12 Recruiting S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Condition: Kidney Cancer
Interventions: Drug: everolimus;   Other: placebo
13 Recruiting International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Conditions: Cardiovascular Diseases;   Coronary Disease;   Coronary Artery Disease;   Heart Diseases;   Myocardial Ischemia
Interventions: Procedure: cardiac catheterization;   Procedure: coronary artery bypass graft surgery;   Procedure: percutaneous coronary intervention;   Behavioral: Lifestyle;   Drug: Medication
14 Not yet recruiting Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection
Conditions: Cervical Cancer;   Precancerous Condition
Intervention: Device: Multispectral Digital Colposcope (MDC)
15 Recruiting Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Other: histological technique;   Other: laboratory biomarker analysis;   Procedure: colposcopic biopsy;   Procedure: colposcopy;   Procedure: light-scattering spectroscopy;   Procedure: loop electrosurgical excision procedure
16 Recruiting Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON) Caused by the G11778A Mutation
Conditions: Leber's Hereditary Optic Neuropathy;   G11778A Gene Mutation;   Human Mitochondrial ND4 Gene
Interventions: Drug: scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: scAAV2-P1ND4v2 1.0X10e11vg (High)

Indicates status has not been verified in more than two years